Global mRNA Cancer Vaccines and Therapeutics Market Growth (Status and Outlook) 2021-2026

Global mRNA Cancer Vaccines and Therapeutics Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2021 growth of mRNA Cancer Vaccines and Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Cancer Vaccines and Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 111.9 million in 2020. Over the next five years the mRNA Cancer Vaccines and Therapeutics market will register a 19.7% CAGR in terms of revenue, the global market size will reach US$ 229.7 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Cancer Vaccines and Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Adeno Carcinomas

Mucinous Carcinomas

Adenosquamous Carcinomas

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Infectious Disease

Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size 2016-2026
2.1.2 mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 mRNA Cancer Vaccines and Therapeutics Segment by Type
2.2.1 Adeno Carcinomas
2.2.2 Adeno Carcinomas
2.2.3 Adenosquamous Carcinomas
2.3 mRNA Cancer Vaccines and Therapeutics Market Size by Type
2.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Type
2.3.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021)
2.4 mRNA Cancer Vaccines and Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Others
2.5 mRNA Cancer Vaccines and Therapeutics Market Size by Application
2.5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Application
2.5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021)
3 mRNA Cancer Vaccines and Therapeutics Market Size by Players
3.1 mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Players
3.1.1 Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global mRNA Cancer Vaccines and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Cancer Vaccines and Therapeutics by Regions
4.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2016-2021)
4.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size Growth (2016-2021)
4.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size Growth (2016-2021)
4.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth (2016-2021)
5 Americas
5.1 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021)
5.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
5.3 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021)
6.2 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
6.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics by Country (2016-2021)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics by Region (2016-2021)
8.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global mRNA Cancer Vaccines and Therapeutics Market Forecast
10.1 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas mRNA Cancer Vaccines and Therapeutics Forecast
10.1.3 APAC mRNA Cancer Vaccines and Therapeutics Forecast
10.1.4 Europe mRNA Cancer Vaccines and Therapeutics Forecast
10.1.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Forecast
10.2 Americas mRNA Cancer Vaccines and Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.2 Canada mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.3 Mexico mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.4 Brazil mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3 APAC mRNA Cancer Vaccines and Therapeutics Forecast by Region (2021-2026)
10.3.1 China mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.2 Japan mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.3 Korea mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.4 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.5 India mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.6 Australia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4 Europe mRNA Cancer Vaccines and Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.2 France mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.3 UK mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.4 Italy mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.5 Russia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.2 South Africa mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.3 Israel mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.4 Turkey mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.5 GCC Countries mRNA Cancer Vaccines and Therapeutics Market Forecast
10.6 Global mRNA Cancer Vaccines and Therapeutics Forecast by Type (2021-2026)
10.7 Global mRNA Cancer Vaccines and Therapeutics Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Information
11.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Moderna Therapeutics Main Business Overview
11.1.5 Moderna Therapeutics Latest Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Offered
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 CureVac Main Business Overview
11.2.5 CureVac Latest Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Information
11.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offered
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Translate Bio Main Business Overview
11.3.5 Translate Bio Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Offered
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Information
11.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Sangamo Therapeutics Main Business Overview
11.5.5 Sangamo Therapeutics Latest Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Information
11.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Argos Therapeutics Main Business Overview
11.6.5 Argos Therapeutics Latest Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Information
11.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offered
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 In-Cell-Art Main Business Overview
11.7.5 In-Cell-Art Latest Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Information
11.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offered
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 eTheRNA Main Business Overview
11.8.5 eTheRNA Latest Developments
11.9 Ethris
11.9.1 Ethris Company Information
11.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Offered
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Ethris Main Business Overview
11.9.5 Ethris Latest Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Information
11.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offered
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Tiba Biotechnology Main Business Overview
11.10.5 Tiba Biotechnology Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook